Search - tctmd.com

Displaying 161 - 180 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

WeChat and Social Media in China

Presenter: Stephanie Gutch, Ajay J. Kirtane, Kefei Dou

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Presenter: Irene M. Lang, Ehtisham Mahmud, Hang Zhang

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Cardiovascular Care in the Era of Facebook

Presenter: Stephanie Gutch, Ajay J. Kirtane, Kapil Yadav

November 01, 2017

Presentation TCT 2017

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Medical Therapy in Group I Pulmonary Arterial Hypertension: Efficacy and Safety

Presenter: Irene M. Lang, Ehtisham Mahmud, Rajesh Gupta

November 01, 2017

Presentation TCT 2017

Clinical Utility of FFRct

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min

November 01, 2017

Presentation TCT 2017

Social Media and Interventional Cardiology: High Risk or Routine?

Presenter: Stephanie Gutch, Ajay J. Kirtane, Asif Qasim

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Social Media: The New Platform for Influence in Interventional Cardiology

Presenter: Stephanie Gutch, Ajay J. Kirtane, Gregory D Matthews

November 01, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Social Media and the Interventionalist: A Great Fit

Presenter: Stephanie Gutch, Ajay J. Kirtane, R. Jay Widmer

November 01, 2017

Presentation TCT 2017

Should Pre-Diabetes Affect Revascularization Decisions?

Presenter: David J. Maron, Alan C. Yeung, Clemens von Birgelen

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

Case Examples of Interventionalists Social Medial Platforms IV

Presenter: C. Michael Gibson, Shelley Wood, Robert W. Yeh

November 01, 2017

Advertisement

WeChat and Social Media in China

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Pulmonary Artery Denervation With a Radiofrequency Catheter: PADN Study Results

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Cardiovascular Care in the Era of Facebook

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Medical Therapy in Group I Pulmonary Arterial Hypertension: Efficacy and Safety

Clinical Utility of FFRct

Social Media and Interventional Cardiology: High Risk or Routine?

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Social Media: The New Platform for Influence in Interventional Cardiology

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Social Media and the Interventionalist: A Great Fit

Should Pre-Diabetes Affect Revascularization Decisions?

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Case Examples of Interventionalists Social Medial Platforms IV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content